SEC Form 4 · accession 0001209191-17-054404
MAGELLAN HEALTH INC · MGLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey N West
Officer — SVP & Controller
Period of report
Sep 28, 2017
Accepted (ET)
Sep 29, 2017 · 4:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000019411
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Common Stock, $0.01 par value | Sep 28, 2017 | X | 15,312 | $32.91 | A | 29,243 | D | |
| Ordinary Common Stock, $0.01 par value | Sep 28, 2017 | X | 2,501 | $42.75 | A | 31,744 | D | |
| Ordinary Common Stock, $0.01 par value | Sep 28, 2017 | X | 2,501 | $49.10 | A | 34,245 | D | |
| Ordinary Common Stock, $0.01 par value | Sep 28, 2017 | X | 2,501 | $47.46 | A | 36,745 | D | |
| Ordinary Common Stock, $0.01 par value | Sep 28, 2017 | X | 2,501 | $53.00 | A | 39,247 | D | |
| Ordinary Common Stock, $0.01 par valueF2 | Sep 28, 2017 | S | 25,316 | $85.8529 | D | 13,931 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F4,F3 | $32.91 | Sep 28, 2017 | X | 15,312 | D | — | Mar 4, 2019 | Common Stock | 15,312 | 0 | D |
| Stock Option (right to buy)F4,F3 | $42.75 | Sep 28, 2017 | X | 2,501 | D | — | Mar 3, 2020 | Common Stock | 2,501 | 15,464 | D |
| Stock Option (right to buy)F4,F3 | $49.10 | Sep 28, 2017 | X | 2,501 | D | — | Mar 3, 2021 | Common Stock | 2,501 | 14,031 | D |
| Stock Option (right to buy)F4,F3 | $47.46 | Sep 28, 2017 | X | 2,501 | D | — | Mar 5, 2022 | Common Stock | 2,501 | 19,636 | D |
| Stock Option (right to buy)F4,F3 | $53.00 | Sep 28, 2017 | X | 2,501 | D | — | Mar 5, 2023 | Common Stock | 2,501 | 18,408 | D |
Explanation of responses
- F1This transaction was effectuated pursuant to a Rule 10b-5-1 Plan.
- F2The number of securities reported represents an aggregate number of shares sold in multiple open market transactions at prices ranging from $85.55 to $86.50, inclusive. The price reported represents the weighted average price. The Reporting Person undertakes to provide staff of the SEC, the issuer, or a stockholder of the issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
- F3All of the stock options in this tranche have vested in full.
- F4Not applicable.